We are live on ! Find out more
TCM

Tao Capital Management Portfolio holdings

AUM $119M
1-Year Est. Return 87.46%
This Fund
S&P 500
This Quarter Est. Return
+20.82%
1 Year Est. Return
+87.46%
3 Year Est. Return
+356.21%
5 Year Est. Return
+280.73%
10 Year Est. Return
AUM
$137M
AUM Growth
+$10.9M
Cap. Flow
-$7.13M
Cap. Flow %
-5.22%
Top 10 Hldgs %
98.97%
Holding
16
New
1
Increased
1
Reduced
Closed
2

Top Buys

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$103K
2
BRDS
Bird Global, Inc.
BRDS
+$3

Top Sells

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$5.93M
2
JOBY icon
Joby Aviation
JOBY
+$1.3M

Sector Composition

Rank Sector Weight
1 Technology 44.69%
2 Healthcare 30.54%
3 Consumer Discretionary 23.08%
4 Consumer Staples 1.69%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBER icon
1
Uber
UBER
$136B
$55.5M 40.62%
1,284,851
TSLA icon
2
Tesla
TSLA
$1.22T
$22.6M 16.53%
86,250
MDGL icon
3
Madrigal Pharmaceuticals
MDGL
$13B
$17.9M 13.14%
77,657
TWST icon
4
Twist Bioscience
TWST
$5.63B
$17M 12.42%
828,815
H icon
5
Hyatt Hotels
H
$18B
$8.02M 5.87%
70,000
OUST icon
6
Ouster
OUST
$2.29B
$5.56M 4.07%
1,125,315
MASS icon
7
908 Devices
MASS
$294M
$3.9M 2.86%
568,981
BHIL
8
DELISTED
Benson Hill, Inc.
BHIL
$2.31M 1.69%
50,705
WRBY icon
9
Warby Parker
WRBY
$3.1B
$1.57M 1.15%
134,473
SOND
10
DELISTED
Sonder
SOND
$851K 0.62%
80,190
GRNA
11
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$802K 0.59%
2,671,664
DNA icon
12
Ginkgo Bioworks
DNA
$493M
$423K 0.31%
5,684
DNLI icon
13
Denali Therapeutics
DNLI
$3.79B
$108K 0.08%
+3,651
New +$103K
BRDS
14
DELISTED
Bird Global, Inc.
BRDS
$74K 0.05%
36,200
+1
+0% +$3
IONQ icon
15
IonQ
IONQ
$13.6B
-963,916
Closed -$5.93M
JOBY icon
16
Joby Aviation
JOBY
$7.08B
-300,000
Closed -$1.3M

Similar funds

Tao Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Tao Capital Management held 16 positions worth $137M, up 8.6% from $126M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Tao Capital Management withdrew a net $7.13M in Q2 2023, closing 2 positions. Its most notable exit was IonQ, an estimated $5.93M position sold in full.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 45% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tao Capital Management opened a new position in Denali Therapeutics worth $108K.

  • Tao Capital Management's largest Q2 2023 buy was Denali Therapeutics: 3,651 shares worth $108K.
  • Tao Capital Management added most to Bird Global, Inc. in Q2 2023, an estimated $3 increase.
  • Tao Capital Management fully exited IonQ in Q2 2023, selling an estimated $5.93M.
  • Tao Capital Management's ten largest holdings make up 99% of its $137M portfolio in Q2 2023.
  • Tao Capital Management opened 1 new position and closed 2 in Q2 2023.
  • Tao Capital Management's portfolio value rose 8.6% quarter-over-quarter to $137M.

Based on Tao Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.